Cargando…
Nutraceuticals for Dyslipidaemia and Glucometabolic Diseases: What the Guidelines Tell Us (and Do Not Tell, Yet)
Background: The use of nutraceutical products and functional foods in the cardiovascular and metabolic field is rising in several countries. Preparation and implementation of guidelines are pivotal for translating research-derived knowledge and evidence-based medicine to the clinical practice. Based...
Autores principales: | Casula, Manuela, Catapano, Alberico Luigi, Magni, Paolo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8839347/ https://www.ncbi.nlm.nih.gov/pubmed/35276964 http://dx.doi.org/10.3390/nu14030606 |
Ejemplares similares
-
LFP and oscillations—what do they tell us?
por: Friston, Karl J, et al.
Publicado: (2015) -
What Is Ageism? Do Our Measures Tell Us?
por: Lee, Jerin, et al.
Publicado: (2020) -
Childhood Wheeze Patterns: What Do They Tell Us?
por: McEvoy, Cindy T., et al.
Publicado: (2022) -
What is AMS telling us?
Publicado: (2016) -
Pathogen Lists Do Not Tell Us What We Need to Do
por: Fedson, David S.
Publicado: (2019)